Cargando…
Tumor necrosis factor α Inhibition for Alzheimer’s Disease
Tumor necrosis factor α (TNF-α) plays a central role in the pathophysiology of Alzheimer’s disease (AD). Food and Drug Administration–approved biologic TNF-α inhibitors are thus a potential treatment for AD, but they do not cross the blood-brain barrier. In this short review, we discuss the involvem...
Autores principales: | Chang, Rudy, Yee, Kei-Lwun, Sumbria, Rachita K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436834/ https://www.ncbi.nlm.nih.gov/pubmed/28579870 http://dx.doi.org/10.1177/1179573517709278 |
Ejemplares similares
-
Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease
por: Sumbria, Rachita K.
Publicado: (2020) -
Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies
por: Chandrashekar, Devaraj V., et al.
Publicado: (2023) -
Inhibition of Inflammation Mediated Through the Tumor Necrosis Factor α Biochemical Pathway Can Lead to Favorable Outcomes in Alzheimer Disease
por: Shamim, Daniah, et al.
Publicado: (2017) -
Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
por: Gareb, Bahez, et al.
Publicado: (2020) -
Neuroinflammation and tumor necrosis factor signaling in the pathophysiology of Alzheimer’s disease
por: McAlpine, Fiona E, et al.
Publicado: (2008)